MedPage Today on MSN
Percutaneous Deep Vein Arterialization Holds Up at 2 Years
Transcatheter arterialization of the deep veins for chronic limb-threatening ischemia in no-option patients kept most ...
As Trump pushes to cap international students, Harvard welcomes its most global class ever — 15% from abroad, 92 countries, ...
Cash and investments are sufficient to fund current operations through Q2 2027, not including VenoValve commercialization and ...
Apogee Therapeutics, Inc. targets atopic dermatitis with APG777, aiming to outperform Dupixent. Learn more about APGE stock ...
Women with a history of chronic pain or chronic widespread pain are more likely to experience a greater burden of menopausal ...
Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA ...
Four dozen tiny pupfish are swimming in a constructed habitat in a giant glass structure once meant to house humans.
The Brighterside of News on MSN
Scientists create special antibody that shuts down rogue T cells safely
A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...
ICSE Class 10 History and Civics Exam Pattern 2025–26 gives a clear idea of the paper format, marking scheme, and ...
The current recommended urine protein to creatinine ratio is arbitrary, and a lower bar would capture more lupus nephritis ...
As the incidence of obesity continues to rise nationally and globally, a new observational study published in Cancer reports ...
Vietnam Investment Review on MSN
Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial
Daewoong Pharmaceutical (Co-CEOs Seong-Soo Park and Chang-Jae Lee) announced that its first-in-class idiopathic pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results